BioNucleon bionucleon.com


Bionucleon is a drug discovery company with a technology platform to produce olibo-based therapeutics. Bionucleon's business strategy is based on a three-branch approach:nnUsing its technology, the company aims to build its own pipeline of therapeutics for inflammatory diseases and angiogenic disorders. Bionucleon collaborates with pharmaceutical and biotechnology companies to create new oligo-based therapeutics against targets of the partner's choosing. Bionucleon generates products for out-li...Show all

Bionucleon is a drug discovery company with a technology platform to produce olibo-based therapeutics. Bionucleon's business strategy is based on a three-branch approach:nnUsing its technology, the company aims to build its own pipeline of therapeut...Show all

Company (Alive / Active)

Phone:

Fax:

c/o Bioindustry Park del Canavese Via Ribes, 5
10010
Italy

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
BioNucleon $0M Mar 19, 2019
See all 18 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related BioNucleon Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Five Prime Therapeutics

South San Francisco, California, United States
IPO / Went publicFive Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discovery capabilities built on its library of secreted and extracellular human proteins, which it leverages in cell-based assays, in vivo models and receptor-ligand matching screens to identify medically relevant new targets and therapeutic proteins. FivePrime has entered into a collaboration agreement to...Show allLogin to see details

Caprion Pharmaceuticals

Montreal, Quebec, Canada
MergedCaprion's leading and proteomics discovery technologies - CellCarta - enable the discovery of targets for therapeutics development and the identification of protein biomarkers that can reduce risk and enhance clinical development productivity and decision making in Pharmaceutical research. In March 2007, Caprion Pharmaceuticals merged with Ecopia BioSciences to form Thallion Pharmaceuticals.Login to see details
See all 18 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Inhibition of hrp-3 using modified oligonucleotides Jun 10, 2009 Apr 29, 2014 Patent